XILIO THERAPEUTICS INC. - COMMON STOCK
1.1600
10-May-24 15:59:51
15 minutes delayed
Stocks
-0.1000
-7.94%
Today's range
1.1100 - 1.3000
ISIN
N/A
Source
NASDAQ
-
01 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
28 Mar 2024 07:05:00 By Nasdaq GlobeNewswire
-
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
28 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 16:01:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference
31 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
07 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
09 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 12:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 17:02:48 By Nasdaq GlobeNewswire
-
05 Sep 2023 08:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
05 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
14 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Promotion of Chris Frankenfield to Chief Operating Officer
03 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
25 May 2023 17:01:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
09 May 2023 07:30:01 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 16:05:01 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Upcoming Investor Conferences
27 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >